Aset Lancar Perubahan Tanggal
Adma Biologics USD 575.86M 47.66M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Cytokinetics USD 1.19B 21.34M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
Heron Therapeutics USD 229.84M 861K 2026-06
Immunic USD 188.76M 165.89M 2026-03
Insmed USD 1.71B 72.59M 2026-09
Knight Therapeutics CAD 394.84M 5.86M 2025-12
MacroGenics USD 321.69M 139.16M 2026-06
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 10.3B 9.68B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Rockwell Medical USD 31.61M 1.42M 2025-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
United Therapeutics USD 2.88B 603.5M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09